AtriCure (ATRC) Tops Q2 EPS by 5c
Tweet
Share
E-mailGet Alerts ATRC Hot Sheet
Price: $59.21 +0.15%
EPS Growth %: -300.0%
Financial Fact:
Income tax expense (benefit): 2K
Today's EPS Names:
VIVO, OCCI, ALZN, More
EPS Growth %: -300.0%
Financial Fact:
Income tax expense (benefit): 2K
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
AtriCure (NASDAQ: ATRC) reported Q2 EPS of ($0.21), $0.05 better than the analyst estimate of ($0.26). Revenue for the quarter came in at $45.2 million versus the consensus estimate of $44.21 million.
For earnings history and earnings-related data on AtriCure (ATRC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- B.Riley Assumes Anika Therapeutics (ANIK) at Buy
- Jana Partners urges Cooper Companies to replace CEO and explore asset sales
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
